Lee L. Eckhardt

Determinants of trafficking, conduction, and disease within a K+ channel revealed through multiparametric deep mutational scanning

The hERG potassium channel and hERG screening for drug-induced torsades de pointes

The genetic basis of long QT and short QT syndromes: A mutation update

Modeling the human Na_v1.5 sodium channel: structural and mechanistic insights of ion permeation and drug blockade

In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes

ER stress-induced cell death mechanisms

Fluoxetine Blocks Nav1.5 Channels via a Mechanism Similar to That of Class 1 Antiarrhythmics

A novel cellular stress response characterised by a rapid reorganisation of membranes of the endoplasmic reticulum

In vitroandin vivomodels for testing arrhythmogenesis in drugs

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

Andersen–Tawil syndrome: Clinical and molecular aspects

Accurate proteome-wide missense variant effect prediction with AlphaMissense

Drug‐induced long QT syndrome: hERG K⁺channel block and disruption of protein trafficking by fluoxetine and norfluoxetine

KCNJ2 mutations in arrhythmia patients referred for LQT testing: A mutation T305A with novel effect on rectification properties

The Interaction of Caveolin 3 Protein with the Potassium Inward Rectifier Channel Kir2.1

Clofilium in the isolated perfused rabbit heart: A new model to study proarrhythmia induced by class III antiarrhythmic drugs

Inward Rectifier Potassium Channels (Kir2.x) and Caveolin-3 Domain–Specific Interaction